The impact of chromosomal microarray on clinical management: a retrospective analysis

@article{Henderson2014TheIO,
  title={The impact of chromosomal microarray on clinical management: a retrospective analysis},
  author={L. Henderson and Carolyn D Applegate and Elizabeth S Wohler and M. Sheridan and J. Hoover-Fong and D. Batista},
  journal={Genetics in Medicine},
  year={2014},
  volume={16},
  pages={657-664}
}
  • L. Henderson, Carolyn D Applegate, +3 authors D. Batista
  • Published 2014
  • Medicine
  • Genetics in Medicine
  • Purpose:Chromosomal microarray has been widely adopted as the first-tier clinical test for individuals with multiple congenital anomalies, developmental delay, intellectual disability, and autism spectrum disorders. Although chromosomal microarray has been extensively shown to provide a higher diagnostic yield than conventional cytogenetic methods, some health insurers refuse to provide coverage for this test, claiming that it is experimental and does not affect patients’ clinical management… CONTINUE READING
    Title The clinical impact of chromosomal microarray on paediatriccare in Hong Kong

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 28 REFERENCES
    Chromosomal microarray impacts clinical management
    63
    Strong Association of De Novo Copy Number Mutations with Autism
    2415